Partners
So Endo is really still indirectly related to TST according to the website statement:
Telesta Therapeutics has granted Paladin Labs (now part of Endo International plc) an exclusive license to market and distribute MCNA for bladder cancer in Canada, South Africa and Mexico. Telesta Therapeutics will be responsible for all product development and manufacturing costs and Paladin will be responsible for all sales and marketing costs in said territories.
I'm sure if news was to be mentioned "behind closed doors" at the conf. by TST.
(It would be)....
Like others, I have been told by TST mgt. that news will be distributed
at the same time for all investors when it is deemed "news".
TST NR stated they are going over the data from adcom with the partners which seems par
for the course. I'm sure Ipsen brings more to the table then TST does in terms of experience
when dealing with things of this nature "a positive".
IMHO, If the value does move up apprx. 8 days after the JP conf. that will be the smoking gun
but then again so many plays go on..."who knows".
MC80 commentary really brings thing to light in terms of the approval possibilities.